Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes
- 11 October 2007
- journal article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 26 (1), 244-253
- https://doi.org/10.1634/stemcells.2007-0267
Abstract
Several recent studies have suggested that the adult bone marrow harbors cells that can influence β-cell regeneration in diabetic animals. Other reports, however, have contradicted these findings. To address this issue, we used an animal model of type 1 diabetes in which the disease was induced with streptozotocin in mice. Freshly prepared sex-mismatched bone marrow cells (BMCs) and syngeneic or allogeneic mesenchymal stem cells (MSCs) were concomitantly administrated into sublethally irradiated diabetic mice. Blood glucose and serum insulin concentrations rapidly returned to normal levels, accompanied by efficient tissue regeneration after a single injection of a mixture of 106 BMCs per 105 MSCs. Neither BMC nor MSC transplantation was effective alone. Successful treatment of diabetic animals was not due to the reconstitution of the damaged islet cells from the transplant, since no donor-derived β-cells were found in the recovered animals, indicating a graft-initiated endogenous repair process. Moreover, MSC injection caused the disappearance of β-cell-specific T lymphocytes from diabetic pancreas. Therefore, we suggest that two aspects of this successful treatment regimen operate in parallel and synergistically in our model. First, BMCs and MSCs induce the regeneration of recipient-derived pancreatic insulin-secreting cells. Second, MSCs inhibit T-cell-mediated immune responses against newly formed β-cells, which, in turn, are able to survive in this altered immunological milieu. Thus, the application of this therapy in human patients suffering from diabetes and/or other tissue destructive autoimmune diseases may be feasible. Disclosure of potential conflicts of interest is found at the end of this article.Keywords
This publication has 54 references indexed in Scilit:
- Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/ scid miceProceedings of the National Academy of Sciences of the United States of America, 2006
- Immunoregulatory function of mesenchymal stem cellsEuropean Journal of Immunology, 2006
- Stem cells and diabetes treatmentAPMIS, 2005
- How to make pancreatic β cells — prospects for cell therapy in diabetesCurrent Opinion in Biotechnology, 2005
- Hepatocyte growth factor is constitutively produced by donor-derived bone marrow cells and promotes regeneration of pancreatic β-cellsBiochemical and Biophysical Research Communications, 2005
- Potential application for mesenchymal stem cells in the treatment of cardiovascular diseasesCanadian Journal of Physiology and Pharmacology, 2005
- Autologous mesenchymal stem cell transplantation in stroke patientsAnnals of Neurology, 2005
- Reversal of experimental diabetes by multiple bone marrow transplantationBiochemical and Biophysical Research Communications, 2005
- Human Pancreatic Islet-Derived Progenitor Cell Engraftment in Immunocompetent MiceThe American Journal of Pathology, 2004
- Presented antigen from damaged pancreatic β cells activates autoreactive T cells in virus-mediated autoimmune diabetesJCI Insight, 2002